ICML 2017

The International Conference on Malignant Lymphoma
Lugano, Switzerland 14-17 June, 2017

The International Conference on Malignant Lymphoma (ICML) 2017 was held in Lugano, Switzerland from 14–17 June, 2017

The 14th biennial meeting saw experts from around the world getting together to present, discuss and debate the latest research and data in malignant lymphoma. The meeting covered a range of subjects related to Hodgkin lymphoma, non-Hodgkin lymphoma, and various lymphoma subtypes. The field is becoming more complex; there are many subtypes of lymphoma and many new agents in development. The outlook for patients is improving and physicians must learn how to use the new agents and techniques to ensure that more patients can benefit from the most up to date guidelines for lymphoma management. Looking beyond the lab and clinic, health economics and the cost of hematological cancer care were also key talking points in Lugano.

This content was supported by Napp Pharmaceuticals Ltd and Janssen Pharmaceuticals (a Johnson & Johnson Company) through an unrestricted educational grant to Magdalen Medical Publishing. These companies had no influence on the production of this content.

Hodgkin Lymphoma

View all

Non-Hodgkin Lymphoma

View all

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi in ex orci. Pellentesque at iaculis sem, at sagittis arcu. Sed tristique accumsan magna, sed aliquam lorem fringilla vitae. Sed mollis nunc eu nisi scelerisque ornare. Etiam viverra magna sed orci finibus blandit. Maecenas sit amet nibh gravida, tincidunt purus tristique, efficitur turpis. Sed id commodo nulla, at dictum risus. Nullam hendrerit eleifend ex, a euismod dui porta et. Aenean sed erat nec turpis sollicitudin tincidunt et a eros. Phasellus malesuada elit nec accumsan feugiat.

Follicular Lymphoma

Diffuse Large B-cell Lymphoma

Mantle Cell Lymphoma

Chronic Lymphocytic Leukemia

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Skip to toolbar